B. Adinoff, G. L. Kramer, and F. Petty, Levels of gammaaminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal, Psychiatry Res, vol.59, pp.137-181, 1995.

A. Agresti and B. Finlay, Statistical Methods for the Social Sciences, 1997.

A. Qatari, M. Khan, S. Harris, and B. , Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain, Alcohol Clin Exp Res, vol.25, pp.1276-83, 2001.

N. N. Aliyev and Z. N. Aliyev, The role of amino-acid transmitters in the pathogenesis of delirium tremens: a brief report, J Stud Alcohol, vol.63, pp.531-534, 2002.

N. A. Aliyev, Z. N. Aliyev, and A. R. Aliguliyev, Amino acid neurotransmitters in alcohol withdrawal, Alcohol Alcohol, vol.29, pp.643-650, 1994.

L. Amato, S. Minozzi, and M. Davoli, Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome, Cochrane Database Syst Rev, vol.15, p.8537, 2011.

, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, 1994.

J. A. Apud, G. Racagni, and E. Iuliano, Role of central nervous system-derived or circulating gamma-aminobutyric acid on prolactin secretion in the rat, Endocrinology, vol.108, pp.1505-1515, 1981.

G. N. Babu, M. Bawari, and V. N. Mathur, Blood glutamate levels inpatients with motor neuron disease, Clin Chim Acta, vol.273, pp.195-200, 1998.

K. Bayerlein, T. Hillemacher, and U. Reulbach, Alcoholism-associated hyperhomocysteinemia and previous withdrawal seizures, Biol Psychiatry, vol.57, pp.1590-1593, 2005.
DOI : 10.1016/j.biopsych.2005.01.046

S. Bleich, D. Degner, and B. Bandelow, Plasma homocysteine is a predictor of alcohol withdrawal seizures, Neuroreport, vol.11, pp.2749-52, 2000.

S. Bleich, D. Degner, and J. Wiltfang, Elevated homocysteine levels in alcohol withdrawal, Alcohol Alcohol, vol.35, pp.351-355, 2000.
DOI : 10.1093/alcalc/35.4.351
URL : https://academic.oup.com/alcalc/article-pdf/35/4/351/9736708/350351.pdf

C. Buddhala, C. C. Hsu, and J. Y. Wu, A novel mechanism for GABA synthesis and packaging into synaptic vesicles, Neurochem Int, vol.55, pp.9-12, 2009.

E. Cagetti, J. Liang, and I. Spigelman, Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors, Mol Pharmacol, vol.63, pp.53-64, 2003.

F. I. Carroll, Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction, Ann N Y Acad Sci, vol.1141, pp.221-253, 2008.
DOI : 10.1196/annals.1441.015

J. Castillo, A. Davalos, and M. Noya, Progression of ischaemic stroke and excitotoxic amino acids, Lancet, vol.349, pp.79-83, 1997.

P. Cushman, Delirium tremens. Update on an old disorder, Postgrad Med, vol.82, pp.117-139, 1987.

P. Cushman, . Jr, and J. R. Sowers, Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment, Alcohol Clin Exp Res, vol.13, pp.361-365, 1989.
DOI : 10.1111/j.1530-0277.1989.tb00336.x

P. Cushman, . Jr, R. Forbes, and W. Lerner, Alcohol withdrawal syndromes: clinical management with lofexidine, Alcohol Clin Exp Res, vol.9, pp.103-111, 1985.
DOI : 10.1111/j.1530-0277.1985.tb05527.x

A. Dahchour, D. Witte, and P. , Excitatory and inhibitory amino acids changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study, Eur J Pharmacol, vol.459, pp.171-179, 2003.

A. Dahchour, D. Witte, and P. , Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods, Alcohol Clin Exp Res, vol.27, pp.465-70, 2003.

A. Dahchour, P. De-witte, and N. Bolo, Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats, Psychiatry Res, vol.82, pp.107-121, 1998.

D. Witte and P. , Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol, Addict Behav, vol.29, pp.1325-1364, 2004.

P. De-witte, E. Pinto, and M. Ansseau, Alcohol and withdrawal: from animal research to clinical issues, Neurosci Biobehav Rev, vol.27, pp.189-97, 2003.

E. Esel, Neurobiology of alcohol withdrawal: inhibitory and excitatory neurotransmitters, Turk Psy Der, vol.17, pp.1-9, 2006.

J. M. Etherington, Emergency management of acute alcohol problems. Part 1: Uncomplicated withdrawal, Can Fam Physician, vol.42, pp.2186-90, 1996.

J. M. Etherington, Emergency management of acute alcohol problems. Part 2: Alcohol-related seizures, delirium tremens, and toxic alcohol ingestion, Can Fam Physician, vol.42, pp.2423-2454, 1996.

J. A. Ewing, Detecting alcoholism: the CAGE questionnaire, J Am Med Assoc, vol.252, pp.1905-1912, 1984.

C. Faingold, Y. Li, and M. S. Evans, Decreased GABA and increased glutamate receptor-mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures, Brain Res, vol.868, pp.287-95, 2000.

J. A. Ferguson, C. J. Suelzer, and G. J. Eckert, Risk factors for delirium tremens development, J Gen Intern Med, vol.11, pp.410-414, 1996.

D. A. Fiellin, P. G. O'connor, and E. S. Holmboe, Risk for delirium tremens in patients with alcohol withdrawal syndrome, Subst Abus, vol.23, pp.83-94, 2002.
DOI : 10.1080/08897070209511478

A. Foy and J. Kay, The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population, Drug Alcohol Rev, vol.14, pp.49-54, 1995.

J. T. Gass and M. F. Olive, Glutamatergic substrates of drug addiction and alcoholism, Biochem Pharmacol, vol.75, pp.218-65, 2008.

R. Gomez, K. L. Behar, and J. Watzl, Intravenous ethanol infusion decreases human cortical ?-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla, Biol Psychiatry, vol.71, pp.239-285, 2012.

W. Hall and D. Zador, The alcohol withdrawal syndrome, Lancet, vol.349, pp.1897-900, 1997.

M. A. Hediger and T. C. Welbourne, Introduction: glutamate transport, metabolism, and physiological responses, Am J Physiol, vol.277, pp.477-80, 1999.
DOI : 10.1152/ajprenal.1999.277.4.f477

M. Heilig, M. Egli, and J. C. Crabbe, Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?, Addict Biol, vol.15, pp.169-84, 2010.

D. Hermann, W. Weber-fahr, and A. Sartorius, Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats, Biol Psychiatry, vol.71, pp.1015-1036, 2012.

T. Hillemacher, H. Frieling, and K. Bayerlein, Biological markers to predict previous alcohol withdrawal seizures: a risk assessment, J Neural Transm, vol.114, pp.151-155, 2007.

A. M. Holbrook, R. Crowther, and A. Lotter, Diagnosis and management of acute alcohol withdrawal, CMAJ, vol.160, pp.675-80, 1999.

A. M. Holbrook, R. Crowther, and A. Lotter, Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal, CMAJ, vol.160, pp.649-55, 1999.

F. Kiefer and K. Mann, Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy, Curr Pharm Des, vol.16, pp.2098-102, 2010.

D. H. Knott, W. D. Lerner, and T. Davis-knott, Decision for alcohol detoxication: a method to standardize patient evaluation, Postgrad Med, vol.69, pp.65-76, 1981.

G. F. Koob, Alcoholism: allostasis and beyond, Alcohol Clin Exp Res, vol.27, pp.232-275, 2003.
DOI : 10.1097/01.alc.0000057122.36127.c2

G. F. Koob, B. J. Mason, D. Witte, and P. , Potential neuroprotective effects of acamprosate, Alcohol Clin Exp Res, vol.26, pp.586-92, 2002.

T. R. Kosten and P. G. O'connor, Management of drug and alcohol withdrawal, Engl J Med, vol.348, pp.1786-95, 2003.

B. D. Kretschmer, W. J. Schmidt, and R. M. Kostrzewa, Amino acids in neurobiology: neuroprotective and neurotoxic aspects of amino acids involved in neurotransmission and neuromodulation -general introduction, Amino Acids, vol.23, pp.1-7, 2002.

E. M. Krupitsky, A. A. Rudenko, and A. M. Burakov, Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam, Alcohol Clin Exp Res, vol.31, pp.604-615, 2007.

E. Küçükibrahimolu, M. Z. Saygin, and M. Calikan, The change in plasma GABA, glutamine and glutamate levels in fluoxetine-or S-citalopram-treated female patients with major depression, Eur J Clin Pharmacol, vol.65, pp.571-578, 2009.

Y. Lecrubier, D. V. Sheehan, and E. Weiller, A short diagnostic structured interview: reliability and validity according to the CIDI, Eur Psychiatry, vol.12, pp.224-255, 1997.

B. I. Liskow, C. Rinck, and J. Campbell, Alcohol withdrawal in the elderly, J Stud Alcohol, vol.50, pp.414-435, 1989.

K. Mann, F. Kiefer, and R. Spanagel, Acamprosate: recent findings and future research directions, Alcohol Clin Exp Res, vol.32, pp.1105-1115, 2008.
DOI : 10.1111/j.1530-0277.2008.00690.x

M. F. Mayo-smith, L. H. Beecher, and T. L. Fischer, Management of alcohol withdrawal delirium. An evidence-based practice guideline, Arch Intern Med, vol.164, pp.1405-1417, 2004.

S. Menard, Applied Logistic Regression Analysis, Sage University Papers Series on Quantitative Applications in the Social Sciences. Series, pp.7-106, 2001.

D. Mennecier, M. Thomas, and P. Arvers, Factors predictive of complicated or severe alcohol withdrawal in alcohol dependent inpatients, Gastroenterol Clin Biol, vol.32, pp.792-799, 2008.

R. Monte, R. Rabuñal, and E. Casariego, Risk factors for delirium tremens in patients with alcohol withdrawal syndrome in a hospital setting, Eur J Intern Med, vol.20, pp.690-694, 2009.

J. Nagy, S. Kolok, and P. Dezso, Differential alterations in the expression of NMDA receptor subunits following chronic ethanol treatment in primary cultures of rat cortical and hippocampal neurones, Neurochem Int, vol.42, pp.35-43, 2003.

M. F. Olive, Interactions between taurine and ethanol in the central nervous system, Amino Acids, vol.23, pp.345-57, 2002.

F. Petty, G. L. Kramer, and L. L. Davis, Plasma gammaaminobutyric acid (GABA) predicts outcome in patients with alcohol dependence, Prog Neuropsychopharmacol Biol Psychiatry, vol.21, pp.809-825, 1997.

S. Rainesalo, T. Keränen, and J. Palmio, Plasma and cerebrospinal fluid amino acids in epileptic patients, Neurochem Res, vol.29, pp.319-343, 2004.

J. D. Reynolds, D. W. Amory, and H. P. Grocott, Change in plasma glutamate concentration during cardiac surgery is a poor predictor of cognitive outcome, J Cardiothorac Vasc Anesth, vol.16, pp.431-437, 2002.

Z. L. Rossetti and S. Carboni, Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum, Eur J Pharmacol, vol.283, pp.177-83, 1995.

A. Roy, J. Dejong, and T. Ferraro, CSF gamma-aminobutyric acid in alcoholics and control subjects, Am J Psychiatry, vol.147, pp.1294-1300, 1990.

M. A. Schuckit, Alcohol-use disorders, Lancet, vol.373, pp.492-501, 2009.

. Société-française-d'alcoologie, Evaluation des pratiques professionnelles en alcoologie, Sevrage en alcool, 2006.

N. Thiercelin, R. Lechevallier, Z. Rusch, and E. , Risk factors for delirium tremens: A literature review, Rev Med Interne, vol.33, pp.18-22, 2012.

G. Tsai, Glutamatergic neurotransmission in alcoholism, J Biomed Sci, vol.5, pp.309-329, 1998.
DOI : 10.1159/000025345

G. E. Tsai, P. Ragan, and R. Chang, Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal, Am J Psychiatry, vol.6, pp.726-758, 1998.

J. C. Umhau, R. Momenan, and M. L. Schwandt, Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study, Arch Gen Psychiatry, vol.67, pp.1069-77, 2010.

G. Vaiva, V. Boss, and F. Ducrocq, Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up, Am J Psychiatry, vol.163, pp.1446-1454, 2006.
DOI : 10.1176/appi.ajp.163.8.1446
URL : https://hal.archives-ouvertes.fr/hal-00333438

B. C. Van-munster, J. C. Korevaar, and S. E. De-rooij, Genetic polymorphisms related to delirium tremens: a systematic review, Alcohol Clin Exp Res, vol.31, pp.177-84, 2007.

V. Vengeliene, A. Bilbao, and A. Molander, Neuropharmacology of alcohol addiction, Br J Pharmacol, vol.154, pp.299-315, 2008.